MARKETS
S&P 5007,619.4+1.31%
NASDAQ 10028,374.3+2.28%
DOW 3052,486.5+0.49%
NIKKEI 22560,819.4-0.70%
DAX26,662.8+1.20%
FTSE 10010,835.5+0.78%
Equities

Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide

Five major companies reported developments this week as the Nasdaq fell 1.65% to 26,755.24 on October 14, 2026: RTX secured a $6.3 billion missile contract, Lockheed Martin debuted the PAC-3 Edge interceptor…

Stock Preachers 9 min read
Market Data by TradingView
Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide

Editor's note: This article has been republished from its original version. Certain sections have been supplemented with a summary, key facts and answers to common questions, each drawn from and verified against the original release. Article also has sponsored disclosure at bottom. The original article can be viewed here.

Key Facts

  • The Nasdaq Composite fell 1.65% to 26,755.24 on October 14, 2026, with a 2.23% weekly loss.
  • RTX's Raytheon secured a $6.3 billion contract for Standard Missile-3 Block IB interceptor production and sustainment over five years with two option years.
  • Lockheed Martin's PAC-3 Edge interceptor will begin testing in 2027 with deployment targeted for 2031 and features a $250 million-invested seeker from its Strigo Product Center.
  • Eli Lilly's exploratory TOGETHER-PsO trial showed the Taltz and Zepbound combination produced 482 differentially expressed proteins at Week 36 versus 140 for Taltz alone.
  • Alimentation Couche-Tard agreed to acquire Irving Oil's retail assets including 50 sites in Quebec and Ontario and 18 cardlock sites, subject to Competition Act approval.
  • IBM advanced to Stage C of DARPA's Quantum Benchmarking Initiative with expectations to deliver its first fault-tolerant quantum system in 2029.

Companies Mentioned

  • IBM (NYSE: IBM)
  • Lockheed Martin (NYSE: LMT)
  • RTX (NYSE: RTX)
  • Alimentation Couche-Tard Inc. (TSX: ATD)
  • Eli Lilly and Company (NYSE: LLY)

Stock Preachers News Commentary

VANCOUVER, BC, Oct. 14, 2026 /PRNewswire/ -- Stocks skidded midweek as the Nasdaq Composite dropped 449 points, or 1.65%, to 26,755.24, pulling its weekly loss to 2.23%. The S&P 500 fell 1.10% on the day and 1.18% for the week, while the Russell 2000 tumbled 1.70% and now carries an RSI of just 28.3, signaling deeply oversold small caps. The Dow held up relatively better, down 0.29%. Gold slid 1.93%, silver dropped 5.81%, and WTI crude bucked the trend, rising 1.36% to $95.42 a barrel. Active Companies from around the markets with current developments this week include: RTX (NYSE: RTX), Lockheed Martin (NYSE: LMT), Eli Lilly and Company (NYSE: LLY), Alimentation Couche-Tard Inc. (TSX: ATD), and IBM (NYSE: IBM).

The broad equity retreat left every major index in the red for the week, with the Nasdaq's 2.23% weekly slide the steepest among the four. The S&P 500 sits just above its 50-day simple moving average support of 7,707.03, while the Dow trades right around its 20-day SMA support near 51,489.97, leaving both indices on the edge of short-term technical floors.

Volatility ticked higher but remained contained, with the VIX up 0.95 points to 16.22 and the VXN rising to 21.14. Both gauges stayed within their recent weekly ranges, suggesting the selloff has not yet triggered panic-level hedging even as the Russell 2000's RSI of 28.3 points to small-cap stress running well ahead of the broader market's unease.

Commodities sent a mixed signal. WTI crude's 1.36% daily gain and 66.18% year-to-date advance stood in sharp contrast to gold's 1.93% drop and silver's 5.81% slide, the latter now down 20.54% year to date. The 10-year Treasury yield edged up 3 basis points to 5.25%, while the euro slipped 0.33% against the dollar.

The full report lays out the index-by-index support and resistance ladder, sector standouts, and what traders are watching into the back half of the week.

The markets are certainly in a see-saw this week, you can read more news on these companies and other sectors at: https://stockpreachers.com/articles/energy-and-pharma-hold-the-fort-as-tech-takes-it-on-the-chin/

In other industry developments and happenings in the market this week include:

RTX (NYSE: RTX) Raytheon, an RTX business, has secured a five-year contract with two additional option years, valued up to $6.3 billion, for the production and sustainment of Standard Missile-3 Block IB interceptors. The award is part of recent agreements between Raytheon and the Department of War supporting replenishment of missile defense inventory used in combat.

RTX (NYSE: RTX) Raytheon, an RTX business, has secured a five-year contract with two additional option years, valued up to $6.

Production will be primarily completed at Raytheon facilities in Tucson, Arizona and Huntsville, Alabama. "This award underscores Raytheon's commitment to increasing production of critical munitions, ensuring our customers have the defensive capabilities they need, when they need them," said Raytheon President Phil Jasper. Read the release.

Lockheed Martin (NYSE: LMT) Lockheed Martin debuted its new PAC-3 Edge interceptor, designed to counter hypersonic and advanced missile threats as part of the U.S. Army's Future Interceptor program. The company will advance development and begin testing in 2027 to prepare for rapid deployment by 2031.

PAC-3 Edge features a Lockheed Martin-built seeker from its Strigo Product Center, which received a $250 million investment, along with a multi-pulse solid rocket motor designed by Northrop Grumman. "Lockheed Martin's PAC-3 Edge interceptor leverages the combat-proven PAC-3 MSE, delivering even greater maneuverability, power and velocity to ensure the Army's layered defensive architecture remains the most advanced in the world," said Tim Cahill, Lockheed Martin, Missiles and Fire Control president. Read the release.

Eli Lilly and Company (NYSE: LLY) Eli Lilly announced new exploratory data from the TOGETHER-PsO Phase 3b trial evaluating Taltz and Zepbound used together versus Taltz alone in adults with moderate-to-severe plaque psoriasis and obesity. By Week 36, the combination showed changes in 482 differentially expressed proteins versus 140 for Taltz alone, and 467 differentially expressed genes versus 16.

Approximately 61% of people with psoriasis also have obesity or overweight with at least one weight-related comorbidity, according to the release. "The broader biomarker changes observed with Taltz and Zepbound, including those associated with skin clearance, may point to a meaningful relationship between immune and metabolic biology," said Mark Genovese, M.D., senior vice president of Lilly Immunology development. Read the release.

Alimentation Couche-Tard Inc. (TSX: ATD) Alimentation Couche-Tard entered a definitive agreement with Irving Oil to acquire retail assets in Quebec and Ontario, including 50 retail sites already operated under the Quebec Alliance, two sites in Pembroke and Cornwall, Ontario, and fuel supply to 71 Couche-Tard owned and operated sites in Quebec.

The deal also covers 18 cardlock sites, 16 in Quebec and two in Ontario, with existing Irving Oil fleet customers continuing to be served under a long-term agreement. "This agreement builds on our longstanding relationship with Irving Oil and our experience operating these locations," said Stephane Trudel, Senior Vice President of Operations at Alimentation Couche-Tard. The transaction is subject to customary closing conditions and regulatory approvals, including under the Competition Act. Read the release.

IBM (NYSE: IBM) IBM announced it has been selected for Stage C, the third phase of DARPA's Quantum Benchmarking Initiative, advancing it through an independent verification process testing quantum hardware, systems engineering and architectures toward building a fault-tolerant quantum computer.

DARPA launched the initiative in 2024 to determine whether an industrially useful fault-tolerant quantum computer can be built by 2033. "IBM expects to deliver the first fault-tolerant system in 2029, and we plan to scale the value of quantum computing well beyond that timeline," said Jay Gambetta, Director of IBM Research and IBM Fellow. Read the release.

Frequently Asked Questions

What contract did RTX's Raytheon business win?

Raytheon secured a five-year contract with two additional option years valued up to $6.3 billion for production and sustainment of Standard Missile-3 Block IB interceptors, with primary production at facilities in Tucson, Arizona and Huntsville, Alabama.

What is Lockheed Martin's PAC-3 Edge interceptor?

PAC-3 Edge is a new interceptor designed to counter hypersonic and advanced missile threats as part of the U.S. Army's Future Interceptor program, with development and testing beginning in 2027 and rapid deployment targeted for 2031.

What did Eli Lilly's TOGETHER-PsO trial show about combining Taltz and Zepbound?

The exploratory Phase 3b trial data showed that by Week 36, the combination of Taltz and Zepbound produced changes in 482 differentially expressed proteins versus 140 for Taltz alone, and 467 differentially expressed genes versus 16.

What assets is Alimentation Couche-Tard acquiring from Irving Oil?

Alimentation Couche-Tard entered a definitive agreement to acquire 50 retail sites in Quebec and Ontario operated under Quebec Alliance, two sites in Pembroke and Cornwall Ontario, 18 cardlock sites, and fuel supply to 71 company-operated sites, subject to customary closing conditions and regulatory approvals including under the Competition Act.

What stage is IBM at in DARPA's Quantum Benchmarking Initiative?

IBM was selected for Stage C, the third phase of the initiative launched in 2024 to determine whether an industrially useful fault-tolerant quantum computer can be built by 2033; IBM expects to deliver its first fault-tolerant system in 2029.

How did the Nasdaq and Russell 2000 perform on October 14, 2026?

The Nasdaq Composite dropped 449 points or 1.65% to 26,755.24, pulling its weekly loss to 2.23%, while the Russell 2000 tumbled 1.70% and carried an RSI of 28.3, signaling deeply oversold small caps.

Sources & Filings

Originally distributed via PR Newswire: Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide

Verify statements about the companies above against their own filings:

Related Coverage

Media Contact: info@stockpreachers.com

Filed under Equities

More on Equities

See all →